Participate in a Study

SCCA was formed, in part, to bring promising new treatments to patients faster. For lung cancer patients this means more treatment options are available at SCCA than might be found elsewhere, including participation in one of many ongoing clinical trials conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine.

Not all patients are cured with standard therapy, and some standard treatments may have more side effects than are desired; therefore, patients may seek help through a clinical trial. Patients who participate in clinical trials have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease.

For more information about clinical trials, see the SCCA Patient Guide to Clinical Trials.

Check here for a list of open lung cancer clinical trials at SCCA. For patients with advanced lung cancer, be sure to check the current roster of open Phase 1 trials.